| Juan P Gonzalez, MD | |
|
2459 Merrick Rd, Bellmore, NY 11710-5703 | |
| (516) 783-4600 | |
| Not Available |
| Full Name | Juan P Gonzalez |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Experience | 31 Years |
| Location | 2459 Merrick Rd, Bellmore, New York |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1104814292 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 205061 (New York) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| White Plains Hospital Center | White plains, NY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| City Medical Of Upper East Side Pllc | 0648465039 | 759 |
| East Post Road Medical Services Pc | 6406198506 | 284 |
News Archive
Lung cancer is the second most common type of cancer and the number one cause of cancer-related mortality. It is estimated that more than 158,000 people will die from lung cancer in the United States this year. Many scientists believe that targeting a type of cell called a cancer stem cell may be necessary to completely cure lung cancer.
Assurances from the Australian Medical Association (AMA) that cancer patients at the Royal Adelaide Hospital are at a minimal risk from an inadvertent 5 per cent reduction in their prescribed radiation dosage between 2004 to 2006, may reassure some but many former patients will still be worried.
Elderly individuals with the metabolic syndrome, a grouping of several common conditions including abdominal obesity, low level of high-density lipoprotein (HDL, the "good cholesterol"), hypertension, and high triglyceride and blood sugar levels, are more likely to experience cognitive impairment than those without this syndrome, according to a study in the November 10 issue of JAMA.
Genentech, Inc., a wholly owned member of the Roche Group, today announced positive results from a Phase II study of trastuzumab-DM1 (T-DM1). As assessed by independent review, T-DM1 shrank the tumors (also known as objective response) in 33 percent of women with advanced (metastatic) HER2-positive breast cancer that had worsened following previous treatment.
› Verified 9 days ago
| Entity Name | White Plains Hospital Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1003089491 PECOS PAC ID: 4981593092 Enrollment ID: O20040420001230 |
News Archive
Lung cancer is the second most common type of cancer and the number one cause of cancer-related mortality. It is estimated that more than 158,000 people will die from lung cancer in the United States this year. Many scientists believe that targeting a type of cell called a cancer stem cell may be necessary to completely cure lung cancer.
Assurances from the Australian Medical Association (AMA) that cancer patients at the Royal Adelaide Hospital are at a minimal risk from an inadvertent 5 per cent reduction in their prescribed radiation dosage between 2004 to 2006, may reassure some but many former patients will still be worried.
Elderly individuals with the metabolic syndrome, a grouping of several common conditions including abdominal obesity, low level of high-density lipoprotein (HDL, the "good cholesterol"), hypertension, and high triglyceride and blood sugar levels, are more likely to experience cognitive impairment than those without this syndrome, according to a study in the November 10 issue of JAMA.
Genentech, Inc., a wholly owned member of the Roche Group, today announced positive results from a Phase II study of trastuzumab-DM1 (T-DM1). As assessed by independent review, T-DM1 shrank the tumors (also known as objective response) in 33 percent of women with advanced (metastatic) HER2-positive breast cancer that had worsened following previous treatment.
› Verified 9 days ago
| Entity Name | City Medical Of Upper East Side Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1801277629 PECOS PAC ID: 0648465039 Enrollment ID: O20101111000052 |
News Archive
Lung cancer is the second most common type of cancer and the number one cause of cancer-related mortality. It is estimated that more than 158,000 people will die from lung cancer in the United States this year. Many scientists believe that targeting a type of cell called a cancer stem cell may be necessary to completely cure lung cancer.
Assurances from the Australian Medical Association (AMA) that cancer patients at the Royal Adelaide Hospital are at a minimal risk from an inadvertent 5 per cent reduction in their prescribed radiation dosage between 2004 to 2006, may reassure some but many former patients will still be worried.
Elderly individuals with the metabolic syndrome, a grouping of several common conditions including abdominal obesity, low level of high-density lipoprotein (HDL, the "good cholesterol"), hypertension, and high triglyceride and blood sugar levels, are more likely to experience cognitive impairment than those without this syndrome, according to a study in the November 10 issue of JAMA.
Genentech, Inc., a wholly owned member of the Roche Group, today announced positive results from a Phase II study of trastuzumab-DM1 (T-DM1). As assessed by independent review, T-DM1 shrank the tumors (also known as objective response) in 33 percent of women with advanced (metastatic) HER2-positive breast cancer that had worsened following previous treatment.
› Verified 9 days ago
| Entity Name | East Post Road Medical Services Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1841767274 PECOS PAC ID: 6406198506 Enrollment ID: O20190419000178 |
News Archive
Lung cancer is the second most common type of cancer and the number one cause of cancer-related mortality. It is estimated that more than 158,000 people will die from lung cancer in the United States this year. Many scientists believe that targeting a type of cell called a cancer stem cell may be necessary to completely cure lung cancer.
Assurances from the Australian Medical Association (AMA) that cancer patients at the Royal Adelaide Hospital are at a minimal risk from an inadvertent 5 per cent reduction in their prescribed radiation dosage between 2004 to 2006, may reassure some but many former patients will still be worried.
Elderly individuals with the metabolic syndrome, a grouping of several common conditions including abdominal obesity, low level of high-density lipoprotein (HDL, the "good cholesterol"), hypertension, and high triglyceride and blood sugar levels, are more likely to experience cognitive impairment than those without this syndrome, according to a study in the November 10 issue of JAMA.
Genentech, Inc., a wholly owned member of the Roche Group, today announced positive results from a Phase II study of trastuzumab-DM1 (T-DM1). As assessed by independent review, T-DM1 shrank the tumors (also known as objective response) in 33 percent of women with advanced (metastatic) HER2-positive breast cancer that had worsened following previous treatment.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Juan P Gonzalez, MD 418-420 5th Avenue, Brooklyn, NY 11215 Ph: (516) 783-4600 | Juan P Gonzalez, MD 2459 Merrick Rd, Bellmore, NY 11710-5703 Ph: (516) 783-4600 |
News Archive
Lung cancer is the second most common type of cancer and the number one cause of cancer-related mortality. It is estimated that more than 158,000 people will die from lung cancer in the United States this year. Many scientists believe that targeting a type of cell called a cancer stem cell may be necessary to completely cure lung cancer.
Assurances from the Australian Medical Association (AMA) that cancer patients at the Royal Adelaide Hospital are at a minimal risk from an inadvertent 5 per cent reduction in their prescribed radiation dosage between 2004 to 2006, may reassure some but many former patients will still be worried.
Elderly individuals with the metabolic syndrome, a grouping of several common conditions including abdominal obesity, low level of high-density lipoprotein (HDL, the "good cholesterol"), hypertension, and high triglyceride and blood sugar levels, are more likely to experience cognitive impairment than those without this syndrome, according to a study in the November 10 issue of JAMA.
Genentech, Inc., a wholly owned member of the Roche Group, today announced positive results from a Phase II study of trastuzumab-DM1 (T-DM1). As assessed by independent review, T-DM1 shrank the tumors (also known as objective response) in 33 percent of women with advanced (metastatic) HER2-positive breast cancer that had worsened following previous treatment.
› Verified 9 days ago
Dr. Fitzgerald Alcindor, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 2459 Merrick Rd, Bellmore, NY 11710 Phone: 516-826-2273 Fax: 516-826-2272 |